84 related articles for article (PubMed ID: 25810318)
1. Inhibition of retinoic acid catabolism by minocycline: evidence for a novel mode of action?
Regen F; Hildebrand M; Le Bret N; Herzog I; Heuser I; Hellmann-Regen J
Exp Dermatol; 2015 Jun; 24(6):473-6. PubMed ID: 25810318
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?
Regen F; Le Bret N; Hildebrand M; Herzog I; Heuser I; Hellmann-Regen J
World J Biol Psychiatry; 2016 Dec; 17(8):634-640. PubMed ID: 26047390
[TBL] [Abstract][Full Text] [Related]
3. Do tetracyclines and erythromycin exert anti-acne effects by inhibition of P450-mediated degradation of retinoic acid?
Hellmann-Regen J; Herzog I; Fischer N; Heuser I; Regen F
Exp Dermatol; 2014 Apr; 23(4):290-3. PubMed ID: 24690039
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of minocycline are mediated by retinoid signaling.
Clemens V; Regen F; Le Bret N; Heuser I; Hellmann-Regen J
BMC Neurosci; 2018 Sep; 19(1):58. PubMed ID: 30241502
[TBL] [Abstract][Full Text] [Related]
5. Striking growth-inhibitory effects of minocycline on human prostate cancer cell lines.
Regen F; Heuser I; Herzog I; Hellmann-Regen J
Urology; 2014 Feb; 83(2):509.e1-6. PubMed ID: 24360070
[TBL] [Abstract][Full Text] [Related]
6. Minocycline modulation of alpha-MSH production by keratinocytes in vitro.
Sainte-Marie I; Tenaud I; Jumbou O; Dréno B
Acta Derm Venereol; 1999 Jul; 79(4):265-7. PubMed ID: 10429980
[TBL] [Abstract][Full Text] [Related]
7. Direct inhibition of retinoic acid catabolism by fluoxetine.
Hellmann-Regen J; Uhlemann R; Regen F; Heuser I; Otte C; Endres M; Gertz K; Kronenberg G
J Neural Transm (Vienna); 2015 Sep; 122(9):1329-38. PubMed ID: 25981674
[TBL] [Abstract][Full Text] [Related]
8. Reduced retinoid signaling in the skin after systemic retinoid-X receptor ligand treatment in mice with potential relevance for skin disorders.
Mihály J; Gericke J; Aydemir G; Weiss K; Carlsen H; Blomhoff R; Garcia J; Rühl R
Dermatology; 2012; 225(4):304-11. PubMed ID: 23296452
[TBL] [Abstract][Full Text] [Related]
9. Tetracycline and minocycline treatment.
Leyden JJ; McGinley KJ; Kligman AM
Arch Dermatol; 1982 Jan; 118(1):19-22. PubMed ID: 6460472
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo.
Reynolds NJ; Fisher GJ; Griffiths CE; Tavakkol A; Talwar HS; Rowse PE; Hamilton TA; Voorhees JJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1636-42. PubMed ID: 8103799
[TBL] [Abstract][Full Text] [Related]
11. The P450 system and mTORC1 signalling in acne.
Melnik BC
Exp Dermatol; 2014 May; 23(5):318-9. PubMed ID: 24588627
[TBL] [Abstract][Full Text] [Related]
12. Human skin levels of retinoic acid and cytochrome P-450-derived 4-hydroxyretinoic acid after topical application of retinoic acid in vivo compared to concentrations required to stimulate retinoic acid receptor-mediated transcription in vitro.
Duell EA; Aström A; Griffiths CE; Chambon P; Voorhees JJ
J Clin Invest; 1992 Oct; 90(4):1269-74. PubMed ID: 1328295
[TBL] [Abstract][Full Text] [Related]
13. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
14. P19 neuronal differentiation and retinoic acid metabolism as criteria to investigate atrazine, nitrite, and nitrate developmental toxicity.
Solari M; Paquin J; Ducharme P; Boily M
Toxicol Sci; 2010 Jan; 113(1):116-26. PubMed ID: 19808863
[TBL] [Abstract][Full Text] [Related]
15. N-retinoyl-D-glucosamine, a new retinoic acid agonist, mediates topical retinoid efficacy with no irritation on photoaged skin.
Kambayashi H; Odake Y; Takada K; Funasaka Y; Ichihashi M; Kato S
Br J Dermatol; 2005 Dec; 153 Suppl 2():30-6. PubMed ID: 16280019
[TBL] [Abstract][Full Text] [Related]
16. All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes.
Schroeder M; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):136-40. PubMed ID: 17326009
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Kraus RL; Pasieczny R; Lariosa-Willingham K; Turner MS; Jiang A; Trauger JW
J Neurochem; 2005 Aug; 94(3):819-27. PubMed ID: 16033424
[TBL] [Abstract][Full Text] [Related]
18. Retinoid signaling by all-trans retinoic acid and all-trans retinoyl-beta-D-glucuronide is attenuated by simultaneous exposure of human keratinocytes to retinol.
Zouboulis CC; Seltmann H; Sass JO; Rühl R; Plum C; Hettmannsperger U; Blume-Peytavi U; Nau H; Orfanos CE
J Invest Dermatol; 1999 Feb; 112(2):157-64. PubMed ID: 9989790
[TBL] [Abstract][Full Text] [Related]
19. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
Ochsendorf F
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
[TBL] [Abstract][Full Text] [Related]
20. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
